KHN has released never-before-seen details of federal audits as the government weighs action against dozens of Medicare Advantage plans.
Readers and listeners shared more than 1,000 personal stories of medical billing problems with KHN-NPR’s “Bill of the Month” investigative series this year, helping us illuminate the financial decisions patients are pressed to make in their most vulnerable moments.
Doctors, consumer advocates, and some lawmakers are looking forward to a California lawsuit against private equity-backed Envision Healthcare. The case is part of a multistate effort to enforce rules banning corporate ownership of physician practices.
An examination of billing policies and practices at more than 500 hospitals across the country shows widespread reliance on aggressive collection tactics.
Emergency room care left Samaria Bradford with $5,000 in medical bills. Now she has to track down and pay that debt before she can hope to enlist in the military.
When Penelope Wingard’s cancer went into remission, she lost her Medicaid coverage in North Carolina. Without insurance, the debts piled up for her follow-up care. She doesn’t think she’ll ever get ahead of it.
Jeff and Kareen King joined a medical cost-sharing plan advertised as a “refreshing non-insurance approach” to paying for health care. It had a big proviso: Preexisting conditions like Jeff’s heart condition were not fully covered for the first two years. He needed heart surgery after just 16 months.
Coal mining ended in Germany’s Saarland a decade ago, but the transition away from coal has been smoother than in West Virginia, which has more medical debt than any state in America.
Facing rare scrutiny from federal auditors, some Medicare Advantage health plans failed to produce any records to justify their payments, government records show. The audits revealed millions of dollars in overcharges to Medicare over three years.
A months-long KHN examination of the system meant to bar fraudsters from Medicaid, Medicare, and other federal health programs found gaping holes and expansive gray areas through which banned individuals slip to repeatedly bilk taxpayer-funded programs.
Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
Some doctors and medical practices voluntarily give rebates on a bill if an injury occurs during a procedure, while others will not, an expert says. Here’s how patients can respond.
Los 1,375 centros de salud financiados con dinero federal, que atienden a 30 millones de estadounidenses de bajos ingresos, son en su mayoría organizaciones privadas. Sin embargo, reciben $6,000 millones anuales en subvenciones federales y, según la ley federal, sus responsabilidades legales están cubiertas por el gobierno
Federally funded clinics and their doctors are protected against lawsuits by federal law, with taxpayers footing the bill. The health centers say that allows them to better serve their low-income patients, but lawyers say the system handcuffs consumers with a cumbersome legal process and makes it harder for the public to see problems.
Taxpayers had to foot the bills for care that should have cost far less, according to records released after KHN filed a lawsuit under the Freedom of Information Act. The government may seek to recover up to $650 million as a result.
Hospitals strike deals with financing companies, generating profits for lenders, and more debt for patients.
Private equity firms have shelled out almost $1 trillion to acquire nearly 8,000 health care businesses, in deals almost always hidden from federal regulators. The result: higher prices, lawsuits, and complaints about care.
Despite the end of Jim Crow segregation, its legacy lives on in medical debt that disproportionately burdens Black communities.
Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?